Literature DB >> 25699146

Pure Diastereomers of a Tranylcypromine-Based LSD1 Inhibitor: Enzyme Selectivity and In-Cell Studies.

Sergio Valente1, Veronica Rodriguez1, Ciro Mercurio2, Paola Vianello3, Bruna Saponara4, Roberto Cirilli4, Giuseppe Ciossani5, Donatella Labella1, Biagina Marrocco1, Giovanni Ruoppolo6, Oronza A Botrugno3, Paola Dessanti3, Saverio Minucci7, Andrea Mattevi5, Mario Varasi3, Antonello Mai8.   

Abstract

The pure four diastereomers (11a-d) of trans-benzyl (1-((4-(2-aminocyclopropyl)phenyl)amino)-1-oxo-3-phenylpropan-2-yl)carbamate hydrochloride 11, previously described by us as LSD1 inhibitor, were obtained by enantiospecific synthesis/chiral HPLC separation method. Tested in LSD1 and MAO assays, 11b (S,1S,2R) and 11d (R,1S,2R) were the most potent isomers against LSD1 and were less active against MAO-A and practically inactive against MAO-B. In cells, all the four diastereomers induced Gfi-1b and ITGAM gene expression in NB4 cells, accordingly with their LSD1 inhibition, and 11b and 11d inhibited the colony forming potential in murine promyelocytic blasts.

Entities:  

Keywords:  Epigenetics; leukemia; lysine-specific demethylase; stereoisomers; tranylcypromine

Year:  2014        PMID: 25699146      PMCID: PMC4329595          DOI: 10.1021/ml500424z

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  34 in total

1.  Synthesis and biological validation of novel synthetic histone/protein methyltransferase inhibitors.

Authors:  Antonello Mai; Sergio Valente; Donghang Cheng; Andrea Perrone; Rino Ragno; Silvia Simeoni; Gianluca Sbardella; Gerald Brosch; Angela Nebbioso; Mariarosaria Conte; Lucia Altucci; Mark T Bedford
Journal:  ChemMedChem       Date:  2007-07       Impact factor: 3.466

Review 2.  Chromatin proteins and modifications as drug targets.

Authors:  Kristian Helin; Dashyant Dhanak
Journal:  Nature       Date:  2013-10-24       Impact factor: 49.962

3.  Targeting Histone Demethylases: A New Avenue for the Fight against Cancer.

Authors:  Dante Rotili; Antonello Mai
Journal:  Genes Cancer       Date:  2011-06

4.  Identification of PR-SET7 and EZH2 selective inhibitors inducing cell death in human leukemia U937 cells.

Authors:  Sergio Valente; Ilaria Lepore; Carmela Dell'Aversana; Maria Tardugno; Sabrina Castellano; Gianluca Sbardella; Stefano Tomassi; Salvatore Di Maro; Ettore Novellino; Roberto Di Santo; Roberta Costi; Lucia Altucci; Antonello Mai
Journal:  Biochimie       Date:  2012-06-16       Impact factor: 4.079

5.  Novel histone demethylase LSD1 inhibitors selectively target cancer cells with pluripotent stem cell properties.

Authors:  Jing Wang; Fei Lu; Qi Ren; Hong Sun; Zhengshuang Xu; Rongfeng Lan; Yuqing Liu; David Ward; Junmin Quan; Tao Ye; Hui Zhang
Journal:  Cancer Res       Date:  2011-10-05       Impact factor: 12.701

6.  Lysine methylation regulates E2F1-induced cell death.

Authors:  Haroula Kontaki; Iannis Talianidis
Journal:  Mol Cell       Date:  2010-07-09       Impact factor: 17.970

7.  High-throughput virtual screening identifies novel N'-(1-phenylethylidene)-benzohydrazides as potent, specific, and reversible LSD1 inhibitors.

Authors:  Venkataswamy Sorna; Emily R Theisen; Bret Stephens; Steven L Warner; David J Bearss; Hariprasad Vankayalapati; Sunil Sharma
Journal:  J Med Chem       Date:  2013-11-23       Impact factor: 7.446

8.  The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation.

Authors:  Jing Wang; Sarah Hevi; Julia K Kurash; Hong Lei; Frédérique Gay; Jeffrey Bajko; Hui Su; Weitao Sun; Hua Chang; Guoliang Xu; François Gaudet; En Li; Taiping Chen
Journal:  Nat Genet       Date:  2008-12-21       Impact factor: 38.330

9.  Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy.

Authors:  Johannes H Schulte; Soyoung Lim; Alexander Schramm; Nicolaus Friedrichs; Jan Koster; Rogier Versteeg; Ingrid Ora; Kristian Pajtler; Ludger Klein-Hitpass; Steffi Kuhfittig-Kulle; Eric Metzger; Roland Schüle; Angelika Eggert; Reinhard Buettner; Jutta Kirfel
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

Review 10.  LSD1 inhibition: a therapeutic strategy in cancer?

Authors:  James T Lynch; William J Harris; Tim C P Somervaille
Journal:  Expert Opin Ther Targets       Date:  2012-09-08       Impact factor: 6.902

View more
  6 in total

1.  Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target Modulation.

Authors:  Rossella Fioravanti; Annalisa Romanelli; Nicola Mautone; Elisabetta Di Bello; Annarita Rovere; Davide Corinti; Clemens Zwergel; Sergio Valente; Dante Rotili; Oronza A Botrugno; Paola Dessanti; Stefania Vultaggio; Paola Vianello; Anna Cappa; Claudia Binda; Andrea Mattevi; Saverio Minucci; Ciro Mercurio; Mario Varasi; Antonello Mai
Journal:  ChemMedChem       Date:  2020-02-14       Impact factor: 3.466

Review 2.  Epigenetic polypharmacology: A new frontier for epi-drug discovery.

Authors:  Daniela Tomaselli; Alessia Lucidi; Dante Rotili; Antonello Mai
Journal:  Med Res Rev       Date:  2019-06-20       Impact factor: 12.944

3.  Towards the development of activity-based probes for detection of lysine-specific demethylase-1 activity.

Authors:  Maria E Ourailidou; Alessia Lenoci; Clemens Zwergel; Dante Rotili; Antonello Mai; Frank J Dekker
Journal:  Bioorg Med Chem       Date:  2016-12-01       Impact factor: 3.641

Review 4.  Structural insight into inhibitors of flavin adenine dinucleotide-dependent lysine demethylases.

Authors:  Hideaki Niwa; Takashi Umehara
Journal:  Epigenetics       Date:  2017-02-10       Impact factor: 4.528

5.  Heterocycle-containing tranylcypromine derivatives endowed with high anti-LSD1 activity.

Authors:  Rossella Fioravanti; Veronica Rodriguez; Jonatan Caroli; Ugo Chianese; Rosaria Benedetti; Elisabetta Di Bello; Beatrice Noce; Clemens Zwergel; Davide Corinti; Dolores Viña; Lucia Altucci; Andrea Mattevi; Sergio Valente; Antonello Mai
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.051

6.  Targeting the scaffolding role of LSD1 (KDM1A) poises acute myeloid leukemia cells for retinoic acid-induced differentiation.

Authors:  Roberto Ravasio; Elena Ceccacci; Luciano Nicosia; Amir Hosseini; Pier Luigi Rossi; Iros Barozzi; Lorenzo Fornasari; Roberto Dal Zuffo; Sergio Valente; Rossella Fioravanti; Ciro Mercurio; Mario Varasi; Andrea Mattevi; Antonello Mai; Giulio Pavesi; Tiziana Bonaldi; Saverio Minucci
Journal:  Sci Adv       Date:  2020-04-08       Impact factor: 14.136

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.